Opportunities EIS Fund

Early stage investment fund providing tax benefits under the Enterprise Investment Scheme (EIS)

Do not invest unless you are prepared to lose all the money you invest. This is a high-risk investment and you are unlikely to be protected if something goes wrong. Take 2 mins to learn more.

Fund at a glance

Type of Fund
EIS Fund
Sector
University spinouts
Investment stage
Series A-C
Portfolio size
8 individual companies
Close date
Evergreen
Target deployment
12-18 months from initial subscription
Min investment
£25,000

Unlocking innovation, maximising tax benefits.

Investment Strategy

The Opportunities EIS Fund is open all year round and will invest in a portfolio of early stage high-growth companies spun out from UK universities. Investors will receive a portfolio of 8 companies across sectors including Quantum Computing, AI, MedTech, Life Sciences, CleanTech and more.

Portfolio Examples

Adsilico

adsilico is developing an end-to-end in-silico trials solution based on virtual ‘synthetic patient populations that will provide better and safer medical devices earlier to patients, reduce costs and accelerate R&D timescales for medical device developers, contribute to animal welfare by reducing animal experimentation.
HealthTech Digital Health MedTech

Adsilico

adsilico is developing an end-to-end in-silico trials solution based on virtual ‘synthetic patient populations that will provide better and safer medical devices earlier to patients, reduce costs and accelerate R&D timescales for medical device developers, contribute to animal welfare by reducing animal experimentation, reducing refining and partially replacing costly and potentially harmful human trials.
Sector
Digital Health, MedTech
Institution
Leeds
Website
adsilico.uk

Oxa

Oxa is an autonomous vehicle software company whose technology operates in any location with zero dependence on external systems i.e. no GPS and no third-party maps. Its autonomous control system, Selenium, is a suite of software that combines data from vehicle sensors to drive autonomous vehicles.
CleanTech Future Mobility

Oxa

Oxa is an autonomous vehicle software company whose technology operates in any location with zero dependence on external systems i.e. no GPS and no third-party maps. Its autonomous control system, Selenium, is a suite of software that combines data from vehicle sensors to drive autonomous vehicles. The Company’s cloud-based fleet management system, Caesium, schedules and co-ordinates autonomous vehicles, optimising routes and exchanging data without human intervention.
Sector
Future Mobility
Institution
Oxford
Website
oxa.tech

Bitfount

Founded in 2020, Bitfount democratises federated AI infrastructure for clinical research, enabling secure collaboration without data sharing. 
Co-founded by Dr Blaise Thomson (former Chief Architect for Siri Understanding at Apple and head of Apple’s Cambridge office) and Dr Naaman Tammuz, the company’s platform connects healthcare providers, pharmaceutical companies.
DeepTech AI Big Data & Software

Bitfount

Founded in 2020, Bitfount democratises federated AI infrastructure for clinical research, enabling secure collaboration without data sharing. The company’s platform connects healthcare providers, pharmaceutical companies, and CROs through privacy-preserving AI networks.
Sector
AI Big Data & Software
Institution
Oxford
Website
www.bitfount.com

EIS-backed ventures reshaping tomorrow

EIS tax reliefs available

Investors will receive individual EIS3 certificates allowing them to claim tax relief.

Taken together, for an additional rate taxpayer, these reliefs can reduce your net exposure so that, in some cases, you may risk as little as 38.5p for every £1 invested.

Please note: Investments must be held for 3 years to achieve all 5 tax reliefs. Tax reliefs are dependent upon investor’s circumstances. The investments described in this website will place your capital at risk. We strongly suggest that you seek specialist tax advice; Parkwalk does not provide investment or tax advice, and the information on this website should not be construed as such. Tax benefits below are as at November 2025. Loss Relief reduces the impact of a loss but does not eliminate it entirely.

Income Tax Relief

Available in the year of investment or carried back to previous year, provided investments are held for three years.
0 %

CGT Disposal Relief

Tax free capital gains on the investments, provided they are held for three years.

Capital Gains Tax Deferral

On gains made in prior three years or for one year following investments.

IHT Free

Provided investments are held for two years and at the time of death. A proposed limit of £1m is due to come into effect from 6th April 2026.

Loss Relief

Optional to claim losses against capital gains or income. This is based on an additional rate taxpayer.
Up to 0 %

Guide to EIS

For more information on EIS tax reliefs, visit our EIS Knowledge Hub. There, you will find a range of educational materials, including guides and articles designed to help you understand the benefits of the scheme.

Looking to invest?

If you’re interested in exploring investment opportunities with Parkwalk, please fill out the form or email us at sales@parkwalkadvisors.com.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Role (select one)
Select the funds you are interested in (select multiple)

Contact us

For more on Parkwalk’s performance, please contact Susie and Harriet at sales@parkwalkadvisors.com.

Susie Harris

Director of Business Development

Susie is responsible for the overall fundraising strategy at Parkwalk, as well as managing strategic partnerships. She spends much of her time presenting Parkwalk’s funds to investors and wealth managers.

Harriet Doherty

Director of Sales and Marketing

Harriet is responsible for the overall marcomms strategy, as well as fundraising for Parkwalk’s EIS Funds – regularly presenting to investors, private clients and wealth managers. Harriet also manages some of the firm’s key strategic IFA relationships.

Funds

Learn about the full range of Parkwalk funds. Discover our flagship and university funds, understand the EIS tax incentives, and find out how to invest.

The products shown on this website will place your capital at risk and investors may not get back the full amount invested. Past performance may not be repeated and is not indicative of future results.

Parkwalk funds invest in smaller and unquoted companies which carry a higher risk than many other forms of investment. There is no guarantee that target returns will be achieved. There is no liquid market for shares in unquoted companies and there can be difficulties, in valuing and disposing of investments in such companies. Tax reliefs will depend on the investors’ individual circumstance and are subject to change.

Parkwalk does not provide investment or tax advice, and the information on this website should not be construed as such. Parkwalk recommends investors seek advice from a regulated financial adviser that specialises in EIS fund investments before making an investment decision. An investment into any of the funds managed by Parkwalk may only be made on the basis of the information set out in the Information Memorandum and Key Information Document.

The information on this website is directed at United Kingdom residents only. Please confirm you have read this warning and are happy to proceed.